Suppr超能文献

病原体相关分子模式对非酒精性脂肪性肝病患者外周血单核细胞的影响

The Effects of Pathogen-Associated Molecular Patterns on Peripheral Blood Monocytes in Patients with Non-alcoholic Fatty Liver Disease.

作者信息

Li Qian, Rempel Julia D, Yang Jiaqi, Minuk Gerald Y

机构信息

Section of Hepatology, University of Manitoba, Winnipeg, Manitoba, Canada.

Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada.

出版信息

J Clin Exp Hepatol. 2022 May-Jun;12(3):808-817. doi: 10.1016/j.jceh.2021.11.011. Epub 2021 Nov 25.

Abstract

BACKGROUND

Innate immune responses to gut-derived pathogen-associated molecular patterns (PAMPs) have been implicated in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Whether NAFLD patients have increased sensitivity to PAMP exposure has yet to be reported.

METHODS

Peripheral blood mononuclear cell (PBMC)/monocytes were exposed to lipopolysaccharide (LPS), Pam3CSK4, or BSA conjugated palmitate . Changes in toll-like receptors (TLR), cytokines, and chemokine receptors (CR) expressions were documented by flow cytometry and/or enzyme-linked immunoabsorbent assays (ELISAs).

RESULTS

TLR2 and TLR4 expression were similar at baseline and increased to a similar extent (TLR2) or remained unchanged (TLR4) following PAMP exposure in NAFLD and healthy control (HC) monocytes. Proinflammatory IL-1β and IL-6 levels were similar at baseline but increased in a concentration-dependent manner to a greater extent in NAFLD PBMCs. CCR1 and CCR2 expressions at baseline were similar and decreased to a similar extent in NAFLD and HC monocytes. The extent of PAMP-induced proinflammatory cytokine release correlated with evidence of hepatocyte injury (CK18M30 levels).

DISCUSSION

NAFLD patients have increased proinflammatory cytokine responses following exposure to PAMPs relative to HC subjects. This response is concentration-dependent and correlates with the extent of hepatic injury.

摘要

背景

对肠道来源的病原体相关分子模式(PAMPs)的先天性免疫反应与非酒精性脂肪性肝病(NAFLD)的发病机制有关。NAFLD患者对PAMP暴露的敏感性是否增加尚未见报道。

方法

将外周血单核细胞(PBMC)/单核细胞暴露于脂多糖(LPS)、Pam3CSK4或牛血清白蛋白偶联棕榈酸酯。通过流式细胞术和/或酶联免疫吸附测定(ELISA)记录Toll样受体(TLR)、细胞因子和趋化因子受体(CR)表达的变化。

结果

在NAFLD和健康对照(HC)单核细胞中,TLR2和TLR4表达在基线时相似,在PAMP暴露后,TLR2表达以相似程度增加(TLR4)或保持不变(TLR4)。促炎细胞因子IL-1β和IL-6水平在基线时相似,但在NAFLD PBMC中以浓度依赖性方式更大程度地增加。CCR1和CCR2在基线时的表达相似,在NAFLD和HC单核细胞中以相似程度降低。PAMP诱导的促炎细胞因子释放程度与肝细胞损伤证据(CK18M30水平)相关。

讨论

与HC受试者相比,NAFLD患者在暴露于PAMPs后促炎细胞因子反应增加。这种反应是浓度依赖性的,并且与肝损伤程度相关。

相似文献

1
The Effects of Pathogen-Associated Molecular Patterns on Peripheral Blood Monocytes in Patients with Non-alcoholic Fatty Liver Disease.
J Clin Exp Hepatol. 2022 May-Jun;12(3):808-817. doi: 10.1016/j.jceh.2021.11.011. Epub 2021 Nov 25.
2
Plasma Oxylipins Levels in Nonalcoholic Fatty Liver Disease.
Dig Dis Sci. 2020 Dec;65(12):3605-3613. doi: 10.1007/s10620-020-06095-8. Epub 2020 Jan 29.
4
Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease.
JHEP Rep. 2020 Oct 9;3(1):100193. doi: 10.1016/j.jhepr.2020.100193. eCollection 2021 Feb.
6
Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease.
World J Gastroenterol. 2014 Jun 21;20(23):7381-91. doi: 10.3748/wjg.v20.i23.7381.
7
CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease.
Am J Physiol Gastrointest Liver Physiol. 2018 Apr 1;314(4):G483-G493. doi: 10.1152/ajpgi.00213.2017. Epub 2018 Feb 8.

引用本文的文献

1
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes.
Front Med (Lausanne). 2025 Aug 14;12:1618275. doi: 10.3389/fmed.2025.1618275. eCollection 2025.
2
Unraveling the Gut-Liver-Brain Axis: Microbiome, Inflammation, and Emerging Therapeutic Approaches.
Mediators Inflamm. 2025 Jun 18;2025:6733477. doi: 10.1155/mi/6733477. eCollection 2025.
3
The Microbiome and Metabolic Dysfunction-Associated Steatotic Liver Disease.
Int J Mol Sci. 2025 Mar 22;26(7):2882. doi: 10.3390/ijms26072882.
4
Gut‑liver axis in liver disease: From basic science to clinical treatment (Review).
Mol Med Rep. 2025 Jan;31(1). doi: 10.3892/mmr.2024.13375. Epub 2024 Oct 25.
7
Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications.
Front Cell Infect Microbiol. 2022 Nov 8;12:997018. doi: 10.3389/fcimb.2022.997018. eCollection 2022.

本文引用的文献

1
Natural Killer Cells and Type 1 Innate Lymphoid Cells Are New Actors in Non-alcoholic Fatty Liver Disease.
Front Immunol. 2019 May 28;10:1192. doi: 10.3389/fimmu.2019.01192. eCollection 2019.
3
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis.
N Engl J Med. 2017 Nov 23;377(21):2063-2072. doi: 10.1056/NEJMra1503519.
4
Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis.
Hepatology. 2018 Apr;67(4):1270-1283. doi: 10.1002/hep.29544. Epub 2018 Feb 19.
5
Treatment of NAFLD with diet, physical activity and exercise.
J Hepatol. 2017 Oct;67(4):829-846. doi: 10.1016/j.jhep.2017.05.016. Epub 2017 May 23.
7
Chronic Low-Grade Inflammation in Childhood Obesity Is Associated with Decreased IL-10 Expression by Monocyte Subsets.
PLoS One. 2016 Dec 15;11(12):e0168610. doi: 10.1371/journal.pone.0168610. eCollection 2016.
8
Innate Immune Cell Trafficking and Function During Sterile Inflammation of the Liver.
Gastroenterology. 2016 Dec;151(6):1087-1095. doi: 10.1053/j.gastro.2016.09.048. Epub 2016 Oct 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验